Navigation Links
Irvine Center for Clinical Research Announces Open Enrollment for New Low Testosterone Study
Date:11/19/2013

IRVINE, Calif., Nov. 19, 2013 /PRNewswire/ -- A recent study by JAMA Internal Medicine revealed that the proportion of middle-aged American men being treated for low testosterone has more than tripled over the last decade. As men test their "T levels," those diagnosed with low testosterone have many treatment options. One option is volunteering for a clinical research study; these studies allow men to try advanced investigational drugs while helping doctors find the medications of tomorrow. The Irvine Center for Clinical Research, a respected and renowned clinical research provider in Southern California, has announced open enrollment for a clinical research study examining an investigational medication on testosterone levels, sex drive, and energy levels in men over the age of 18.

"There are alarming statistics regarding low testosterone in men. According to the American Diabetes Association, nearly 13 million American men may be affected. More than half of men with low testosterone report erectile dysfunction and most say they have a low sex drive," said Dr. Denny Lee, Principal Investigator, Irvine Center for Clinical Research. "We need men who are experiencing these symptoms to participate in clinical studies and volunteer to take research study medications. Only through research studies like these can doctors find safer and more effective treatments."

Normal testosterone levels range from 300 to 1,000 nanograms per deciliter of blood, according to the U.S. National Library of Medicine. A low reading means the testicles are not producing enough testosterone. Men who have been diagnosed with low testosterone may experience symptoms such as reduced sex drive, reduced energy, reduced strength as well as sexual dysfunction, and may want to consider joining a clinical study.

Qualified participants of the clinical research study may receive 9 months' dosage of investigational medication at no cost, as well as travel and time reimbursements of up to $400. Interested parties should contact Irvine Center for Clinical Research to learn more and schedule a no-cost screening and consultation.

To learn more about the low testosterone study being conducted at Irvine Center for Clinical Research or to see if you qualify, visit www.irvineclinical.com.

About Irvine Center for Clinical Research
Irvine Center for Clinical Research is an independent medical research clinic in Irvine, California, specializing in researching investigational medications and providing study-related care to participants at no cost. Since its original founding in 1978, Irvine Center for Clinical Research has delivered research opportunities and solutions to men and women in the greater Los Angeles area. The team at Irvine Center for Clinical Research is staffed by full-time principal investigators, clinical research coordinators, laboratory and regulatory staff, and takes pride in developing the best possible physician-patient relationship with each new study. To learn more about Irvine Center for Clinical Research, visit www.irvineclinical.com.

CONTACT:
Claire Delacruz Soe
Soe Communications Group
(310) 962-8467
claire@soe-pr.com


'/>"/>
SOURCE Irvine Center for Clinical Research
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Pro-Dex, Inc. Partners with UC Irvine School of Engineering
2. Agendia Earns ISO Certification for Facilities in Amsterdam and Irvine
3. Vermillion Announces Positive Top-Line Results from the OVA500 Multi-Center Study Led by UC Irvine
4. Kareo Launches New Solution Center to Enable Private Practice Success
5. WuXi PharmaTech Announces Licensing Agreement for Patient-Derived Xenograft Models with Mayo Clinics Center for Individualized Medicine
6. JDRF Teams Up with Pfizers Centers for Therapeutic Innovation to Support Novel Translational Research in Type 1 Diabetes
7. Ariosa Diagnostics Selected as NIPT Service Provider in Majority of California Comprehensive Prenatal Diagnosis Centers Throughout the State
8. Biotest Opens New Plasma Center in Melbourne, Florida
9. BD Launches BD Helping Build Healthy Communities with Direct Relief and the National Association of Community Health Centers
10. InCube Labs Enters into an Agreement with the Engineering Research Center for Revolutionizing Metallic Biomaterials
11. DNA Diagnostics Center (DDC), One of the Worlds Largest DNA Testing Companies, Increases the Identification Power of its DNA Tests by More Than 500%
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/2/2017)... , Oct. 2, 2017  AllianceRx Walgreens Prime, ... formed by Walgreens and pharmacy benefit manager Prime Therapeutics ... new brand, which included the unveiling of new signage ... , as well as at a few other company-owned ... new brand to patients, some of whom will begin ...
(Date:9/28/2017)... , Sept. 28, 2017 Hill-Rom Holdings, Inc. ... earnings conference call and webcast on Friday, November 3, ... (EDT) and ending at approximately 8:30 a.m. (CDT) / ... the company,s 2017 financial performance and guidance for 2018, ... initiatives to enhance operational performance, and long-range financial outlook ...
(Date:9/27/2017)... and NEW YORK , Sept. 27, 2017 /PRNewswire/ ... health and big data solutions, today announced that its MyDario product is ... your local TV listings for when The Dr. Oz Show airs in ... The nine-time ... month. ...
Breaking Medicine Technology:
(Date:10/12/2017)... ... October 12, 2017 , ... CitiDent and San Francisco ... using cutting-edge Oventus O2Vent technology. As many as 18 million Americans are estimated ... in breathing. Oral appliances can offer significant relief to about 75 percent of ...
(Date:10/12/2017)... ... October 12, 2017 , ... The ... demand of today’s consumer and regulatory authorities worldwide. From Children’s to Adults 50+, ... to meet the highest standard. , These products are also: Gluten Free, ...
(Date:10/12/2017)... ... , ... The American College of Medical Informatics (ACMI) will present the 2017 ... Session of AMIA’s Annual Symposium in Washington, D.C. AMIA’s Annual Symposium is ... pioneer in the field of medical informatics, this prestigious award is presented to an ...
(Date:10/12/2017)... ... October 12, 2017 , ... Information about the ... to develop to enable prevention of a major side effect of chemotherapy in ... in pediatric patients. For cisplatin, hearing loss is FDA listed on-label as a ...
(Date:10/12/2017)... ... October 12, 2017 , ... HMP , a ... of a 2017 Folio Magazine Eddie Digital Award for ‘Best B-to-B Healthcare Website.’ Winners ... October 11, 2017. , The annual award competition recognizes editorial and design excellence across ...
Breaking Medicine News(10 mins):